X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Orchid Chemicals with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   ADCOCK INGRAM
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ADCOCK INGRAM
Jun-14
ORCHID PHARMA LTD/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs194353-   
Low Rs35255-   
Sales per share (Unadj.) Rs276.5105.0-  
Earnings per share (Unadj.) Rs-79.2-26.5-  
Cash flow per share (Unadj.) Rs-43.5-21.9-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.982.4-  
Shares outstanding (eoy) m70.45168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.42.9 14.3%   
Avg P/E ratio x-1.4-11.5 12.6%  
P/CF ratio (eoy) x-2.6-13.9 19.0%  
Price / Book Value ratio x2.13.7 57.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,06751,290 15.7%   
No. of employees `0002.84.3 65.2%   
Total wages/salary Rs m2,5273,219 78.5%   
Avg. sales/employee Rs Th6,956.14,129.2 168.5%   
Avg. wages/employee Rs Th902.5749.8 120.4%   
Avg. net profit/employee Rs Th-1,993.0-1,040.5 191.5%   
INCOME DATA
Net Sales Rs m19,47717,727 109.9%  
Other income Rs m407124 328.0%   
Total revenues Rs m19,88417,851 111.4%   
Gross profit Rs m1,103-3,072 -35.9%  
Depreciation Rs m2,519765 329.3%   
Interest Rs m5,227480 1,088.5%   
Profit before tax Rs m-6,236-4,193 148.7%   
Minority Interest Rs m20-12 -168.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125262 -47.8%   
Profit after tax Rs m-5,580-4,467 124.9%  
Gross profit margin %5.7-17.3 -32.7%  
Effective tax rate %2.0-6.2 -32.1%   
Net profit margin %-28.7-25.2 113.7%  
BALANCE SHEET DATA
Current assets Rs m11,01412,983 84.8%   
Current liabilities Rs m32,0607,305 438.9%   
Net working cap to sales %-108.132.0 -337.3%  
Current ratio x0.31.8 19.3%  
Inventory Days Days95111 85.5%  
Debtors Days Days34124 27.1%  
Net fixed assets Rs m29,4407,568 389.0%   
Share capital Rs m70582 856.0%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,80013,914 27.3%   
Long term debt Rs m9,0184,889 184.4%   
Total assets Rs m46,51026,284 177.0%  
Interest coverage x-0.2-7.7 2.5%   
Debt to equity ratio x2.40.4 675.3%  
Sales to assets ratio x0.40.7 62.1%   
Return on assets %-0.8-15.2 5.0%  
Return on equity %-146.9-32.1 457.4%  
Return on capital %-3.7-19.8 18.9%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,6821,513 111.1%  
From Investments Rs m-9,860-465 2,122.4%  
From Financial Activity Rs m6,6444,438 149.7%  
Net Cashflow Rs m-1,5355,486 -28.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.87 Rs / ZAR

Compare ORCHID PHARMA LTD With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA LTD With: CLARIS LIFESCIENCES  DR. DATSONS LABS  TORRENT PHARMA  BIOCON LTD  FDC LTD.  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - NOVARTIS COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS